This announcement is a separate document:
首药控股（北京）股份有限公司自愿披露关于SY-7166获得药物临床试验批准通知书的公告
Shuoyao Holdings (Beijing) Co., Ltd. voluntarily disclosed the announcement of SY-7166 obtaining the notice of drug clinical trial approval.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.